Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 MDXHEALTH MDXH Apr 26, 2018 3.79 +25.25   
 MEDIVISION MEDV Apr 26, 2018 0.01 0.00   
 MELEXIS MELE Apr 26, 2018 79.15 +1.54   
 MIKO MIKO Apr 26, 2018 116.00 +1.75   
 MITHRA MITRA 0.00 0.00   
 MOBISTAR MOBB Apr 26, 2018 16.84 +0.96   
 MONTEA C.V.A. MONT Apr 26, 2018 44.30 0.00   
 MOPOLI MOP Apr 26, 2018 290.00 0.00   
 MOURY CONSTRUCT MOUR Apr 26, 2018 138.00 0.00   
 NEUFCOUR-FIN. NEU Apr 26, 2018 7.50 0.00   
 NR21 NR21 0.00 0.00   
 NYRSTAR NYR Apr 26, 2018 5.68 -0.87   
 OIM OIM Apr 26, 2018 0.55 0.00   
 ONTEX GROUP ONTEX Apr 26, 2018 20.66 +2.38   
 OPTION OPTI Apr 26, 2018 0.06 +2.71   
 ORANGE BELGIUM OBEL 0.00 0.00   
 PAYTON PLANAR PAY Apr 26, 2018 3.94 0.00   
 PCB PCBB Apr 26, 2018 7.65 0.00   
 PICANOL PIC Apr 26, 2018 93.60 +0.21   
 PROXIMUS PROX Apr 26, 2018 25.21 +0.48   
 QRF QRF 0.00 0.00   
 QUESTFOR GR-PRICAF QFG Apr 26, 2018 7.70 0.00   
 REALDOLMEN REA Apr 26, 2018 36.90 0.00   
 RECTICEL REC Apr 26, 2018 10.20 -0.20   
 RESILUX RES Apr 26, 2018 140.60 -0.42   
 RETAIL ESTATES RET Apr 26, 2018 72.40 +2.26   
 ROSIER ENGB Apr 26, 2018 170.00 +4.29   
 ROULARTA ROU Apr 26, 2018 22.30 +0.45   
 RTL GROUP RTL Apr 26, 2018 68.65 +0.07   
 SABCA SAB Apr 26, 2018 27.40 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now